SE385885B - Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat - Google Patents
Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivatInfo
- Publication number
- SE385885B SE385885B SE7112534-8A SE1253471A SE385885B SE 385885 B SE385885 B SE 385885B SE 1253471 A SE1253471 A SE 1253471A SE 385885 B SE385885 B SE 385885B
- Authority
- SE
- Sweden
- Prior art keywords
- amino
- procedure
- preparation
- arylpyrimidine derivatives
- arylpyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7821670A | 1970-10-05 | 1970-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE385885B true SE385885B (sv) | 1976-07-26 |
Family
ID=22142671
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7112534-8A SE385885B (sv) | 1970-10-05 | 1971-10-04 | Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat |
| SE7410488A SE390304B (sv) | 1970-10-05 | 1971-10-04 | Analogiforfarande for framstellning av 4-hydroxi-5-etyl-6-fonylpyrimidin |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7410488A SE390304B (sv) | 1970-10-05 | 1971-10-04 | Analogiforfarande for framstellning av 4-hydroxi-5-etyl-6-fonylpyrimidin |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3707560A (fi) |
| JP (2) | JPS5648511B1 (fi) |
| AT (4) | AT314540B (fi) |
| AU (1) | AU465734B2 (fi) |
| BE (1) | BE773484A (fi) |
| CA (1) | CA988519A (fi) |
| CH (4) | CH554875A (fi) |
| DE (2) | DE2149249C3 (fi) |
| DK (1) | DK131858C (fi) |
| ES (4) | ES395676A1 (fi) |
| FI (1) | FI55502C (fi) |
| FR (1) | FR2110227B1 (fi) |
| GB (2) | GB1373536A (fi) |
| NL (1) | NL168511C (fi) |
| SE (2) | SE385885B (fi) |
| ZA (1) | ZA716615B (fi) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3859288A (en) * | 1970-10-05 | 1975-01-07 | Pfizer | Arylpyrimidines - inhibitors of platelet aggregation and bronchodilators |
| US3908012A (en) * | 1970-10-05 | 1975-09-23 | Pfizer | Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators |
| US3895112A (en) * | 1970-10-05 | 1975-07-15 | Pfizer | Arylpyrimidines in the relaxation of smooth muscle |
| US3835132A (en) * | 1972-02-01 | 1974-09-10 | Shell Oil Co | Morpholino-piperazinyl pyrimidines |
| US3950525A (en) * | 1973-06-19 | 1976-04-13 | Pfizer Inc. | Relaxation of smooth muscle in a mammal |
| DE2343419A1 (de) * | 1973-08-29 | 1975-03-13 | Gruenenthal Chemie | Verfahren zur herstellung von pyrimidinderivaten |
| US4725600A (en) * | 1984-07-13 | 1988-02-16 | Fujisawa Pharmaceutical Co., Ltd. | Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent |
| US4935516A (en) * | 1988-01-29 | 1990-06-19 | Ube Industries, Ltd. | Process for preparing 4-hydroxypyrimidine |
| JPH0625157B2 (ja) * | 1988-01-29 | 1994-04-06 | 宇部興産株式会社 | ４―ヒドロキシピリミジン類の製造方法 |
| DE3825647A1 (de) * | 1988-07-28 | 1990-02-01 | Geyer Gmbh & Co Christian | Vorrichtung zur befestigung eines elektrischen schaltgeraetes |
| DE3905364A1 (de) * | 1989-02-22 | 1990-08-23 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool |
| JP2003505384A (ja) * | 1999-07-15 | 2003-02-12 | ファーマコピーア，インコーポレーティッド | ブラジキニンｂ１受容体アンタゴニスト |
| ES2290436T3 (es) * | 2002-03-15 | 2008-02-16 | Ciba Specialty Chemicals Holding Inc. | Uso de 4-aminopiridinas para el tratamiento antimicrobiano de superficies. |
| DE60335635D1 (de) * | 2002-05-22 | 2011-02-17 | Amgen Inc | Aminopyrimidin-derivate zur verwendung als vanilloid-rezeptor-liganden zur behandlung von schmerzen |
| WO2004085433A2 (en) * | 2003-03-28 | 2004-10-07 | Pharmacia & Upjohn Company Llc | Positive allosteric modulators of the nicotinic acetylcholine receptor |
| US20060235036A1 (en) * | 2005-04-15 | 2006-10-19 | Doherty Elizabeth M | Vanilloid receptor ligands and their use in treatments |
| JP2009164373A (ja) * | 2008-01-08 | 2009-07-23 | Toshiba Corp | 半導体装置 |
| CN102811620B (zh) * | 2010-01-25 | 2015-03-25 | Chdi基金会股份有限公司 | 一些犬尿氨酸-3-单加氧酶抑制剂、药物组合物及其使用方法 |
| AU2012300246A1 (en) | 2011-08-30 | 2014-03-06 | Chdi Foundation, Inc. | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| EA027451B1 (ru) | 2011-08-30 | 2017-07-31 | Схди Фаундейшн, Инк. | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и их применение |
| SG11201700341PA (en) | 2014-07-17 | 2017-02-27 | Chdi Foundation Inc | Methods and compositions for treating hiv-related disorders |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3047462A (en) * | 1959-03-06 | 1962-07-31 | Lab Jacques Logeais Soc D Expl | Quinazolone anti-inflammatory composition |
-
1970
- 1970-10-05 US US78216A patent/US3707560A/en not_active Expired - Lifetime
-
1971
- 1971-09-30 FI FI2734/71A patent/FI55502C/fi active
- 1971-10-01 DK DK480171A patent/DK131858C/da not_active IP Right Cessation
- 1971-10-02 DE DE2149249A patent/DE2149249C3/de not_active Expired
- 1971-10-02 DE DE2165962A patent/DE2165962C2/de not_active Expired
- 1971-10-04 ES ES395676A patent/ES395676A1/es not_active Expired
- 1971-10-04 CA CA124,312A patent/CA988519A/en not_active Expired
- 1971-10-04 GB GB3831673A patent/GB1373536A/en not_active Expired
- 1971-10-04 GB GB4615871A patent/GB1373535A/en not_active Expired
- 1971-10-04 SE SE7112534-8A patent/SE385885B/xx unknown
- 1971-10-04 ZA ZA716615A patent/ZA716615B/xx unknown
- 1971-10-04 SE SE7410488A patent/SE390304B/xx unknown
- 1971-10-05 AT AT858071A patent/AT314540B/de not_active IP Right Cessation
- 1971-10-05 AT AT605473A patent/AT317229B/de not_active IP Right Cessation
- 1971-10-05 CH CH1521472A patent/CH554875A/fr not_active IP Right Cessation
- 1971-10-05 NL NLAANVRAGE7113670,A patent/NL168511C/xx not_active IP Right Cessation
- 1971-10-05 AT AT00149/73A patent/AT316563B/de not_active IP Right Cessation
- 1971-10-05 CH CH1452971A patent/CH554876A/fr not_active IP Right Cessation
- 1971-10-05 CH CH772973A patent/CH542218A/fr not_active IP Right Cessation
- 1971-10-05 JP JP7823771A patent/JPS5648511B1/ja active Pending
- 1971-10-05 CH CH1532172A patent/CH554346A/fr not_active IP Right Cessation
- 1971-10-05 AT AT00148/73A patent/AT315856B/de not_active IP Right Cessation
- 1971-10-05 BE BE773484A patent/BE773484A/xx not_active IP Right Cessation
- 1971-10-05 FR FR7135815A patent/FR2110227B1/fr not_active Expired
- 1971-10-06 AU AU34259/71A patent/AU465734B2/en not_active Expired
-
1973
- 1973-11-02 ES ES420209A patent/ES420209A1/es not_active Expired
- 1973-11-02 ES ES420211A patent/ES420211A1/es not_active Expired
- 1973-11-02 ES ES420210A patent/ES420210A1/es not_active Expired
-
1980
- 1980-08-11 JP JP11016380A patent/JPS5636468A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE398877B (sv) | Forfarande for framstellning av 14-hydroxi-morfinanderivat | |
| SE385885B (sv) | Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat | |
| SE394678B (sv) | Analogiforfarande for framstellning av pyridokinolinderivat | |
| SE384368B (sv) | Forfarande for framstellning av 6-substituerade - 4 - amino- 1,2 - dihydro - 1 - hydroxi - 2 - iminopyrimidiner | |
| SE395149B (sv) | Forfarande for framstellning av dibenso-tiepinylpiperazinderivat | |
| NO138883C (no) | Fremgangsmaate for fremstilling av oksiranforbindelser | |
| SE403106B (sv) | Forfarande vid framstellning av 14-hydroximorfinanderivat | |
| SE401676B (sv) | Forfarande for framstellning av dibensofuranderivat | |
| SE399701B (sv) | Forfarande for framstellning av hydroxyalkyldiamin | |
| SE394436B (sv) | Forfarande for framstellning av 7-halogen-linkomyciner | |
| SE7511680L (sv) | Forfarande for framstellning av furanderivat | |
| SE380273B (sv) | Forfarande for framstellning av tiopyrimidinderivat | |
| SE392615B (sv) | Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat | |
| SE385011B (sv) | Forfarande for framstellning av alfa-linkosaminider | |
| SE384685B (sv) | Forfarande for framstellning av linkomycinderivat | |
| SE395897B (sv) | Forfarande for framstellning av 7beta-acylamido-3-metyl-cef-3-em-4-karbonsyror | |
| SE395699B (sv) | Forfarande for framstellning av kinuklidin-kinolinderivat | |
| SE408418B (sv) | Forfarande for framstellning av 5-fluor-pyrimidiner | |
| SE408177B (sv) | Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat | |
| SE380795B (sv) | Forfarande for framstellning av tiokarbamider | |
| SE411759B (sv) | Forfarande for framstellning av erytromycyliminforeningar | |
| NO136409C (no) | Fremgangsm}te for fremstilling av aryloksyalkyl-morfolinderivater | |
| SE382046B (sv) | Forfarande for framstellning av 1-aryloxi-2-propanol | |
| SE382051B (sv) | Forfarande for framstellning av 3-sulfonamid-4-hydroxifenyl-2-piperidylkarbinoler | |
| SE397350B (sv) | Forfarande for framstellning av tieno-diazepinderivat |